ID   USPC-ARK-18
AC   CVCL_IV89
SY   USPC-ARK18
DR   Wikidata; Q54991959
RX   PubMed=23891627;
CC   Population: African American.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
RX   PubMed=23891627; DOI=10.1016/j.ajog.2013.07.020;
RA   English D.P., Bellone S., Cocco E., Bortolomai I., Pecorelli S.,
RA   Lopez S., Silasi D.-A., Schwartz P.E., Rutherford T.J., Santin A.D.;
RT   "Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications
RT   determine the sensitivity of uterine serous carcinoma cell lines to
RT   GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase
RT   (TORC1/2).";
RL   Am. J. Obstet. Gynecol. 209:465.e1-465.e9(2013).
//